These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 32244416

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Radiotherapy in combination with nivolumab for relapsed/refractory classical Hodgkin lymphoma: About two cases.
    de Forceville L, Deau-Fischer B, Franchi P, Arsène-Henry A, Cassou Mounat T, Bouscary D, Kirova YM.
    Cancer Radiother; 2019 Jun; 23(3):232-239. PubMed ID: 31147173
    [Abstract] [Full Text] [Related]

  • 3. Early 18F-FDG PET/CT Response Predicts Survival in Relapsed or Refractory Hodgkin Lymphoma Treated with Nivolumab.
    Chen A, Mokrane FZ, Schwartz LH, Morschhauser F, Stamatoullas A, Schiano de Colella JM, Vercellino L, Casasnovas O, Chauchet A, Delmer A, Nicolas-Virelizier E, Ghesquières H, Moles-Moreau MP, Schmitt A, Dulery R, Bouabdallah K, Borel C, Touati M, Deau-Fischer B, Peyrade F, Seban RD, Manson G, Armand P, Houot R, Dercle L.
    J Nucl Med; 2020 May; 61(5):649-654. PubMed ID: 31628220
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Development of Resistant GvHD in a Patient Treated with Nivolumab for Hodgkins Lymphoma Relapse after Allogeneic Unrelated Transplantation.
    Steinerová K, Jindra P, Lysák D, Karas M.
    Klin Onkol; 2019 May; 32(1):66-69. PubMed ID: 30764632
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expression of PD-1/PD-L1 in children's classical Hodgkin lymphomas.
    Dilly-Feldis M, Aladjidi N, Refait JK, Parrens M, Ducassou S, Rullier A.
    Pediatr Blood Cancer; 2019 May; 66(5):e27571. PubMed ID: 30637917
    [Abstract] [Full Text] [Related]

  • 17. Interstitial nephritis associated with nivolumab in a patient with hodgkin lymphoma.
    Oliveira DS, Mesquita JL, Garcia YDO, Rosales YMZ, Lemes RPG, Rocha Filho FD, Fernandes PFCBC, Duarte PMA, Pitombeira MDS, Duarte FB.
    Rev Assoc Med Bras (1992); 2019 Aug 05; 65(7):934-936. PubMed ID: 31389500
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Back to life with checkpoint inhibitors in Hodgkin lymphoma.
    Dada R, Zekri J.
    J Oncol Pharm Pract; 2018 Mar 05; 24(2):139-142. PubMed ID: 28597713
    [Abstract] [Full Text] [Related]

  • 20. [Checkpoint inhibitors in Hodgkin lymphoma].
    Sasse S, Momotow J, Engert A.
    Internist (Berl); 2020 Jul 05; 61(7):660-668. PubMed ID: 32462248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.